Bioactive food components in the diet of patients diagnosed with cancer
DOI:
https://doi.org/10.15584/ejcem.2017.1.3Keywords:
cancer, bioactive food components, diet, nutrigenomics, epigeneticsAbstract
Introduction. Cancer, after cardiovascular disease, is the second most common cause of death both in Poland and Europe, so it is important to investigate and search for dietary components with anti-cancer properties. Components which can modulate different stages of carcinogenesis through epigenetic process are called bioactive food components.
Aim. The aim of this study was to evaluate nutritional habits of patients diagnosed with cancer in terms of level of bioactive food components consumption.
Material and methods. A group of 123 patients diagnosed with cancer were enrolled the study. The study was conducted by means of an anonymous questionnaire on diet history prepared by the authors. Statistical analysis was performed using IBM SPSS software, statistical significance was adopted at the level of p < 0.05.
Results. Based on the results of the questionnaires, major risk factors that increase the prevalence of cancer disease were age (above 55 years) and increased BMI (the score indicated overweight or obesity). Additionally, it was observed that cancer diagnosis resulted in change of eating habits in approx. 61.8% of the participants. Enrolled patients mostly consumed inadequate amounts of green vegetables, legumes, green tea and whole grains before the diagnosis. Moreover, patients with breast and colorectal cancer were found to be more likely to consume more red meat in comparison to others. – Both non-modifiable factors: age and modifiable ones: body weight and lifestyle influence morbidity. – Most participants ate incorrectly before cancer diagnosis; diagnosis of the disease changed their eating habits.
Downloads
References
World Health Organization. The European Health Report 2012: charting the way to well-being [Internet]. Report [updated 2012; cited 2013]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0004/197113/EHR2012-Eng.pdf
Potrykowska A, Strzelecki Z, Szymborski J, Witkowski J, redakcja. Cancer incidence and mortality versus the demographic situation of Poland. Warszawa: Rządowa Rada Ludnościowa; 2014.
World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR, 2007 Available from: www.aicr.org/assets/docs/pdf/reports/Second_Expert_Report.pdf
Tuorkey MJ. Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing. Interv Med Appl Sci. 2014;6:4:139-46.
Stefanska B, Karlic H, Varga F, et al. Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention. Br J Pharmacol. 2012;167:2:279-97.
Supic G, Jagodic M, Magic Z. Epigenetics: a new link between nutrition and cancer. Nutr Cancer. 2013;65:6:781-92.
Liu RH. Dietary bioactive compounds and their health implications. J Food Sci. 2013;78:1:18-25.
Daniel M, Tollefsbol TO. Epigenetic linkage of aging, cancer and nutrition. J Exp Biol. 2015;218:1:59-70.
Busch C, Burkard M. et al. Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin Epigenetics. 2015;10;7:1:64.
Bal J. Biologia molekularna w medycynie. Elementy genetyki klinicznej. Warszawa: PWN; 2013.
Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:4:693-705.
Ross SA, Davis CD. MicroRNA, nutrition, and cancer prevention. Adv Nutr. 2011;2:6:472-85.
Su LJ, Mahabir S, Ellison GL, et al. Epigenetic Contributions to the Relationship between Cancer and Dietary Intake of Nutrients, Bioactive Food Components, and Environmental Toxicants. Front Genet. 2012;9;2:91.
Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature. 2004;5:931–945.
Bedyńska S. Brzezicka A. Statystyczny drogowskaz, Warszawa 2007.
Nawojczyk M. Przewodnik po statystyce dla socjologów, Kraków 2002.
Data were provided by the Office for National Statistics on request, June 2016. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78.
Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16:1:36-46.
Yang CS, Fang M, Lambert JD, et al. Reversal of hypermethylation and reactivation of genes by dietary polyphenolic compounds. Nutr Rev. 2008;66:1:18-20.
Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2009; 8;3:CD005004.
Yuan JM. Cancer prevention by green tea: evidence from epidemiologic studies. Am J Clin Nutr. 2013;98:6:1676-1681.
Juan ME, Alfaras I, Planas JM. Colorectal cancer chemoprevention by trans-resveratrol. Pharmacol Res. 2012;65:6:584-91.
Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL. Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res. 2010;54:7–16.
Weiskirchen S, Weiskirchen R. Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy? Adv Nutr. 2016;15;7:4:706-18.
Artero A, Artero A, Tarín JJ, Cano A. The impact of moderate wine consumption on health. Maturitas. 2015;80:1:3-13.
Hayes JD, Kelleher MO, Eggleston IM. The cancer chemopreventive actions of phytochemicals derived from glucosinolates. European Journal of Nutrition 2008;47:2:73-88.
Hecht SS. Inhibition of carcinogenesis by isothiocyanates. Drug Metabolism Reviews 2000;32:3-4:395-411.
Tse G, Eslick GD, Cruciferous vegetables and risk of colorectal neoplasms: a systematic review and meta-analysis.Nutr Cancer. 2014;66:1:128-39.
Liu X, Lv K. Cruciferous vegetables intake is inversely associated with risk of breast cancer: a meta-analysis.Breast. 2013;22:3:309-13.
Li LY, Luo Y, Lu MD, et al. Cruciferous vegetable consumption and the risk of pancreatic cancer: a meta-analysis. World J Surg Oncol. 2015;12:13:44.
Han B, Li X, Yu T. Cruciferous vegetables consumption and the risk of ovarian cancer: a meta-analysis of observational studies. Diagn Pathol. 2014;20;9:7.
Liu B, Mao Q, Cao M, Xie L. Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis. Int J Urol. 2012;19:2:134-41.
Galeone C, Pelucchi C, Levi F, et al. Onion and garlic use and human cancer. The American journal of clinical nutrition. 2006;84:1027–32.
Nicastro HL, Ross SA, Milner JA. Garlic and onions: their cancer prevention properties. Cancer Prev Res (Phila). 2015;8:3:181-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 European Journal of Clinical and Experimental Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.




